INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 41 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,000 | -30.0% | 13,063 | 0.0% | 0.00% | – |
| Q4 2017 | $10,000 | -47.4% | 13,063 | 0.0% | 0.00% | – |
| Q3 2017 | $19,000 | -40.6% | 13,063 | +8.3% | 0.00% | -100.0% |
| Q2 2017 | $32,000 | +3.2% | 12,063 | +59.5% | 0.00% | 0.0% |
| Q1 2017 | $31,000 | +24.0% | 7,563 | +26.8% | 0.00% | 0.0% |
| Q4 2016 | $25,000 | -39.0% | 5,963 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $41,000 | +51.9% | 5,963 | +22.0% | 0.00% | 0.0% |
| Q2 2016 | $27,000 | – | 4,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|